May 04,2023

Wyden Announces Finance Committee Hearing on Big Pharma’s Tax Avoidance Schemes

WASHINGTON, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., will convene a committee hearing on Thursday, May 11th, 2023 titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The hearing will take place at 10:00 a.m. in Room 215 of the Dirksen Senate Office Building.

The witnesses at Thursday’s hearing will be:

  1. Brad W. Setser, Whitney Shepherdson Senior Fellow, Council on Foreign Relations
  2. Diane M. Ring, Professor of Law, Boston College Law School
  3. William Morris, Deputy Global Tax Policy Leader, PwC
  4. Daniel Bunn, President and CEO, Tax Foundation

Who:    Senate Finance Committee

What:   Committee hearing on Big Pharma’s tax avoidance schemes and the effects of the 2017 Republican tax law. 

Where: 215 Dirksen Senate Office Building

              Washington, D.C. 20510

When: Thursday, May 11th, 2023

             10:00 a.m.

Media are encouraged to attend the hearing or to view the webcast and witness testimony at http://finance.senate.gov/hearings.

###